These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26011730)

  • 1. An Orally Active Phenylaminotetralin-Chemotype Serotonin 5-HT7 and 5-HT1A Receptor Partial Agonist that Corrects Motor Stereotypy in Mouse Models.
    Canal CE; Felsing DE; Liu Y; Zhu W; Wood JT; Perry CK; Vemula R; Booth RG
    ACS Chem Neurosci; 2015 Jul; 6(7):1259-70. PubMed ID: 26011730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of novel 5-substituted-2-aminotetralin analogs: 5-HT
    Perry CK; Casey AB; Felsing DE; Vemula R; Zaka M; Herrington NB; Cui M; Kellogg GE; Canal CE; Booth RG
    Bioorg Med Chem; 2020 Feb; 28(3):115262. PubMed ID: 31882369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knowledge-Based Design of Long-Chain Arylpiperazine Derivatives Targeting Multiple Serotonin Receptors as Potential Candidates for Treatment of Autism Spectrum Disorder.
    Lacivita E; Niso M; Mastromarino M; Garcia Silva A; Resch C; Zeug A; Loza MI; Castro M; Ponimaskin E; Leopoldo M
    ACS Chem Neurosci; 2021 Apr; 12(8):1313-1327. PubMed ID: 33792287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic and pharmacokinetic studies in rats of S-8-(2-Furyl)- and R-8-phenyl-2-(di-n-propylamino) tetralin, two novel 5-HT1A receptor agonists in-vitro with different properties in-vivo.
    Yu H; Liu Y; Li HB; Martin AR; Hacksell U; Lewander T
    J Pharm Pharmacol; 1997 Feb; 49(2):169-77. PubMed ID: 9055190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin 6 receptor blockade reduces repetitive behavior in the BTBR mouse model of autism spectrum disorder.
    Amodeo DA; Oliver B; Pahua A; Hitchcock K; Bykowski A; Tice D; Musleh A; Ryan BC
    Pharmacol Biochem Behav; 2021 Jan; 200():173076. PubMed ID: 33220385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents.
    Leopoldo M; Berardi F; Colabufo NA; Contino M; Lacivita E; Niso M; Perrone R; Tortorella V
    J Med Chem; 2004 Dec; 47(26):6616-24. PubMed ID: 15588097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repetitive behavior profile and supersensitivity to amphetamine in the C58/J mouse model of autism.
    Moy SS; Riddick NV; Nikolova VD; Teng BL; Agster KL; Nonneman RJ; Young NB; Baker LK; Nadler JJ; Bodfish JW
    Behav Brain Res; 2014 Feb; 259():200-14. PubMed ID: 24211371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel aminotetralin-type serotonin (5-HT) 2C receptor-specific agonist and 5-HT2A competitive antagonist/5-HT2B inverse agonist with preclinical efficacy for psychoses.
    Canal CE; Morgan D; Felsing D; Kondabolu K; Rowland NE; Robertson KL; Sakhuja R; Booth RG
    J Pharmacol Exp Ther; 2014 May; 349(2):310-8. PubMed ID: 24563531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FPT, a 2-Aminotetralin, Is a Potent Serotonin 5-HT
    Saraf TS; McGlynn RP; Bhatavdekar OM; Booth RG; Canal CE
    ACS Chem Neurosci; 2022 Dec; 13(24):3629-3640. PubMed ID: 36473166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviors following administration of the neurotoxin 3-acetylpyridine.
    Wieland S; Kreider MS; McGonigle P; Lucki I
    Brain Res; 1990 Jun; 520(1-2):291-302. PubMed ID: 1698505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction to an orally active phenylaminotetralin-chemotype serotonin 5-HT7 and 5-HT1A receptor partial agonist that corrects motor stereotypy in mouse models.
    Canal CE; Felsing DE; Liu Y; Zhu W; Wood JT; Perry CK; Vemula R; Booth RG
    ACS Chem Neurosci; 2015 Aug; 6(8):1486. PubMed ID: 26225542
    [No Abstract]   [Full Text] [Related]  

  • 12. Privileged scaffold-based design to identify a novel drug-like 5-HT
    Lacivita E; Niso M; Stama ML; Arzuaga A; Altamura C; Costa L; Desaphy JF; Ragozzino ME; Ciranna L; Leopoldo M
    Eur J Med Chem; 2020 Aug; 199():112395. PubMed ID: 32442850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of selective antagonists of serotonin 5-HT7 and 5-HT1A receptors on MK-801-induced impairment of learning and memory in the passive avoidance and Morris water maze tests in rats: mechanistic implications for the beneficial effects of the novel atypical antipsychotic lurasidone.
    Horisawa T; Ishibashi T; Nishikawa H; Enomoto T; Toma S; Ishiyama T; Taiji M
    Behav Brain Res; 2011 Jun; 220(1):83-90. PubMed ID: 21277905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Density and function of central serotonin (5-HT) transporters, 5-HT1A and 5-HT2A receptors, and effects of their targeting on BTBR T+tf/J mouse social behavior.
    Gould GG; Hensler JG; Burke TF; Benno RH; Onaivi ES; Daws LC
    J Neurochem; 2011 Jan; 116(2):291-303. PubMed ID: 21070242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological profile of (-)HT-90B, a novel 5-HT1A receptor agonist/5-HT2 receptor antagonist.
    Uchida H; Inagawa K; Tameda C; Miyauchi T
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Nov; 19(7):1201-16. PubMed ID: 8787043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bimodal effects of MK-801 on locomotion and stereotypy in C57BL/6 mice.
    Wu J; Zou H; Strong JA; Yu J; Zhou X; Xie Q; Zhao G; Jin M; Yu L
    Psychopharmacology (Berl); 2005 Jan; 177(3):256-63. PubMed ID: 15290006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically effective OCD treatment prevents 5-HT1B receptor-induced repetitive behavior and striatal activation.
    Ho EV; Thompson SL; Katzka WR; Sharifi MF; Knowles JA; Dulawa SC
    Psychopharmacology (Berl); 2016 Jan; 233(1):57-70. PubMed ID: 26423528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT1A and 5-HT7 receptors contribute to lurasidone-induced dopamine efflux.
    Huang M; Horiguchi M; Felix AR; Meltzer HY
    Neuroreport; 2012 May; 23(7):436-40. PubMed ID: 22415605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuating effects of prior oestradiol benzoate priming on 5-HT-mediated lordosis behavior in rats are dose-dependent.
    Siddiqui A; Shaharyar S
    Acta Physiol Hung; 2007 Sep; 94(3):209-21. PubMed ID: 17853773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the role of brain 5-HT7 receptor in the mechanism of hypothermia: comparison with hypothermia mediated via 5-HT1A and 5-HT3 receptor.
    Naumenko VS; Kondaurova EM; Popova NK
    Neuropharmacology; 2011 Dec; 61(8):1360-5. PubMed ID: 21884711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.